Myomo (MYO): Rosalind reports 9.9% stake, 3.79M shares
Myomo, Inc. received an amended Schedule 13G reporting that Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon collectively beneficially own 9.9% of Myomo’s common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Myomo, Inc. received an amended Schedule 13G reporting that Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon collectively beneficially own 9.9% of Myomo’s common stock. The filing references 38,435,524 shares outstanding as of November 3, 2025.
The reported position reflects 3,790,788 shares of common stock and an additional 3,763,258 pre-funded warrants that are subject to a 9.99% “blocker”, which prevents exercises that would push ownership above that level. As a result, the warrants were not exercisable as of the event date, and the reporting persons indicate passive intent under Schedule 13G certifications.
Insights
Passive 13G/A discloses a capped 9.9% stake with blocker.
Rosalind entities report beneficial ownership of 9.9% in Myomo (MYO), based on 38,435,524 shares outstanding as of November 3, 2025. The stake includes 3,790,788 common shares plus 3,763,258 pre-funded warrants that are contractually restricted.
The warrants carry a 9.99% beneficial ownership limitation, preventing exercises that would push holdings above that threshold. The certification states the securities were acquired and are held in the ordinary course, without intent to influence control.
This is an ownership disclosure rather than a transaction; market impact depends on future holder decisions and any subsequent filings that update share counts or ownership.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in MYO does Rosalind report in this Schedule 13G/A?
What is the purpose of the 9.99% blocker on the pre-funded warrants?
Do the reporting persons indicate a control intent over MYO?
Who are the reporting persons in this MYO 13G/A?
AI-generated analysis. How Rhea-AI works. Not financial advice.